menu

News

8/18/2014 Archer Lynden Archer, the William C. Hooey Director and Professor of Chemical and Biomolecular Engineering, has received the 2014 Nanoscale Science and Engineering Forum (NSEF) Award from the American Institute of Chemical Engineers (AICHE).
8/14/2014   Loeckenhoff Corinna Loeckenhoff, associate professor of human development, is the 2014 recipient of the Margret M. and Paul B.
8/13/2014 By Bill Steele A smartphone app to assist people with bipolar disorder, conceived by Cornell researchers, has won the prestigious $100,000 Heritage Open mHealth Challenge.

Pages

Other Cornell Stories

10/31/2014

“Expanded Communities and Posthumanity” will feature scholars from a wide range of disciplines exploring the field of posthumanities on campus Nov. 5-6.

10/31/2014

Robert F. Engle, M.S. ’66, Ph.D. ‘69, who won the 2003 Nobel Memorial Prize in Economic Sciences, spoke on campus Oct. 24 about economics models that can stave off another financial crisis.

10/30/2014

The Cornell Center for Materials Research’s JumpStart program, funded by New York state, helps small businesses solve issues with materials.

10/30/2014

Third-year Cornell Law School student Fatmata Kabia is raising funds to support the next issue of Memunatu, a magazine she founded that serves West African teenage girls.

10/30/2014

Students Cornell Veterinary School, the Cornell Institute for Public Affairs and SUNY-Cortland are raising funds for the Belize Zoo.

10/30/2014

Events on campus include the Prague Philharmonic Choir in concert, writer Todd Miller on border issues, a Messenger Lecture by theater scholar David Román, and a social entrepreneurship institute.

10/30/2014

Seeking support, anorexics get "negative enabling" taunts from their online peers.

10/30/2014

Artist Chon Noriega, curator of a 1993 Arts Quad exhibition that led to the takeover of Day Hall by Latino students, recalled the events in a campus talk Oct. 28.

10/30/2014

A pathogenic fungus that infects salamanders and newts has jumped out of Southeast Asia and threatens species worldwide.

10/30/2014

A first clinical trial of ultrasmall, multifunctional particles called "C dots" (Cornell dots) has deemed them safe for humans and cleared easily by the body.